Living with vulval lichen sclerosus : unheard stories and silenced voices by Rees, Sophie
Case Reports in Women's Health 29 (2021) e00271
Contents lists available at ScienceDirect
Case Reports in Women's Health
j ourna l homepage: www.e lsev ie r .com/ locate /c rwhInvited EditorialLiving with vulval lichen sclerosus: Unheard stories
and silenced voicesA R T I C L E I N F O
Article history:
Received 26 October 2020






Qualitative researchVulval lichen sclerosus (VLS) is a chronic skin condition affecting
the vulval skin and often also involves the skin around the anus. A
2020 Finnish study found VLS to be commonest in prepubertal girls
and postmenopausal women [1], but it may occur at any age. VLS
has a major impact on everyday activities. Women's self-identity
may be profoundly threatened. VLS causes intense itching and painful
tears in the vulval skin, and can result in architectural changes such as
narrowing of the vaginal entrance and burying of the clitoris [2]. It is
also associated with an increased risk of vulval cancer, with up to
60% of vulval cancers occurring on a background of VLS [2]. VLS is a
chronic condition which cannot be cured. Evidence from a cohort
study in Australia, however, indicates that long-term topical highly
potent steroid treatment may be effective in preventing flare-ups
and malignancy [3]. VLS is often misdiagnosed, sometimes repeatedly
for many years, as recurrent thrush [4]. If a clinician suspects a patient
may have VLS, they should refer them to an experienced dermatolo-
gist for diagnosis and ongoing care.
A 2015 survey from the British Association of Dermatology found
that one in five women with a vulval condition had considered suicide
or self-harm as a result of their condition [5]. Those affected may be
embarrassed to talk about it, and thus receive no support from their so-
cial network. Yet vulval conditions continue to be a neglected area of re-
search. Randomised controlled trials of new, expensive, treatments for
VLS may be appealing, but do we really understand the experience
and therefore understand how best to improve it? If topical steroids
are effective and inexpensive, do we understand what it is actually
like to apply a highly potent steroid ointment to the genitals potentially
for the rest of one's life? Do patients consider this a good enough
treatment?
We badly need evidence from the perspective of patients in order to
understand how best to support them. Qualitative and mixed-methodshttps://doi.org/10.1016/j.crwh.2020.e00271
2214-9112/© 2020 The Author. Published by Elsevier B.V. This is an open access article undersocial research is a powerful way of understanding an illness from the
perspective of those experiencing the phenomenon. Findings can be
used to inform the design of supportive interventions and improve
healthcare pathways. They can also help us prioritise research. For ex-
ample, do those with VLS wish us to prioritise researching new treat-
ments, improving access to swift diagnosis, or increasing patients'
confidence to self-manage the condition?
Evidence on the experience of VLS is extremely limited [6]. Just two
published studies exist which have used qualitative methods to explore
the topic [4,7,8]. These found that affected women struggle to access di-
agnosis and care, and that they seek alternative and complementary
treatments.We need to understand the obstacles to diagnosis and treat-
ment, in order to identity how to improve access for all by developing
better pathways to diagnosis for all affected women. Reasons for lack
of satisfaction with mainstream treatment need to be further explored.
Some studies have used quantitative methods to demonstrate the pro-
found impact of VLS on sexual function [9–13], but greater depth on
this and on other domains of life affected byVLS is badly needed. The ex-
perience of VLS needs to be understood in its context, including the gen-
der norms which shape experiences of VLS and decisions to undergo
vulval surgery [7], and the societal stigma around the vulva.
Any evidence base about the experience of VLS would be incom-
plete if it does not include the voices of minority ethnic patients. Fur-
thermore, research should seek to include disabled patients, and also
transmasculine and non-binary people. These groups may experience
particular barriers to diagnosis and treatment. A poor understanding
of skin conditions in people of colour is currently a topic of discus-
sion [14]. Those seeking help for VLS symptoms must additionally
contend with the lack of knowledge amongst GPs of the condition
[15], plus societal stigma attached to talking about the vulva. Finding
pictures online of a ‘normal’ vulva is made more difficult for thosethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
S. Rees Case Reports in Women's Health 29 (2021) e00271with black or brown skin, and whose bodies are racialised and
sexualised. Transmasculine and non-binary people will experience
particular obstacles in accessing urogynaecological services, as they
are forced into spaces which are less accommodating or welcoming
to them.
There are many unanswered clinically-oriented questions about
VLS. There are also many, many unheard stories and silenced voices.
Accessing and amplifying these voices is crucial to increase research
in the area, tackle the stigma attached to the condition, and improve
access to swift diagnosis, optimal care, and a better quality of life for
those with VLS.
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